Lower extremity arterial reconstruction for critical limb ischemia in diabetes Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai,

Slides:

Advertisements

Similar presentations

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Advertisements

Progression of atherosclerosis in asymptomatic carotid arteries after contralateral endarterectomy: A 10-year prospective study Enzo Ballotta, MD, Giuseppe.

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.

Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia Jayer Chung, MD, J. Gregory Modrall, MD, Chul.

Endovascular therapy for acute limb ischemia

Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia Hani Slim, MD, MRCS, Alok Tiwari,

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Vascular access in hemodialysis patients older than 80 years

Richard R. Proia, MD, Daniel B. Walsh, MD, Peter R. Nelson, MD, John P

Long-term survival and stroke-free survival after eversion carotid endarterectomy for asymptomatic severe carotid stenosis Enzo Ballotta, MD, Giorgio.

Durability of eversion carotid endarterectomy

The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery Jasper van der Slegt, MD, Stijn L. Steunenberg,

Jack R. W. Brownrigg, MBChB, Michelle Griffin, MBChB, Cian O

Initial clinical experience with a polytetrafluoroethylene vascular dialysis graft reinforced with nitinol at the venous end Filippo Benedetto, MD, PhD,

Increased warm ischemia time during vessel harvest decreases the primary patency of cryopreserved conduits in patients undergoing lower extremity bypass

Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage Caren Randon, MD, Bart Jacobs, MD, Frederik.

Endoscopic versus open saphenous vein graft harvest for lower extremity bypass in critical limb ischemia Raymond E. Eid, MD, Li Wang, MS, Michael Kuzman,

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

The efficacy of salvage interventions on threatened distal bypass grafts Sanjay Dhanji Patel, FRCS, Vassilios Zymvragoudakis, MD, Lisa Sheehan, MRCS,

The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease Enzo Ballotta, MD, Mario Gruppo, MD, Renata.

Prosthetic lower extremity hemodialysis access grafts have satisfactory patency despite a high incidence of infection Irma L. Geenen, MD, Lydia Nyilas,

Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia Hasan H. Dosluoglu, MD, Purandath Lall,

Endoscopic vein harvest does not negatively affect patency of great saphenous vein lower extremity bypass Sikandar Z. Khan, MD, Mariel Rivero, MD, Brian.

Axillopopliteal bypass for limb salvage

Durability of open popliteal artery aneurysm repair

The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia Maria Söderström, MD,

Thrombolysis for lower extremity bypass graft occlusion

Cryopreserved saphenous vein graft in infrainguinal bypass

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Reshma P. Duffy, MD, Julie E. Adams, MD, Peter W

Percutaneous intervention for infrainguinal occlusive disease in women: Equivalent outcomes despite increased severity of disease compared with men Brian.

Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England Meghan Dermody, MD, MS, Christopher Homsy, MD, Yuanyuan.

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery Michael.

Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss Raghuveer Vallabhaneni,

Outcomes of reinterventions after subintimal angioplasty

Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions Gautam V. Shrikhande, MD,

A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia

Open versus endoscopic great saphenous vein harvest for lower extremity revascularization of critical limb ischemia Vincent J. Santo, MD, Phong T. Dargon,

Number of infrapopliteal arteries undergoing endovascular treatment is not associated with the limb salvage rate in patients with critical limb ischemia

Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure Vincent J. Santo, MD, Phong.

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative Jeffrey J. Siracuse, MD, Matthew.

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

James T. McPhee, MD, Philip P

A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease Norman R.

Early and long-term outcomes of carotid endarterectomy in the very elderly: An 18-year single-center study Enzo Ballotta, MD, Giuseppe Da Giau, MD, Mario.

A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical.

Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Carotid endarterectomy for asymptomatic carotid stenosis in the very elderly Enzo Ballotta, MD, Antonio Toniato, MD, Anna Da Roit, MD, Renata Lorenzetti,

Eric C. Scott, MD, Andre Biuckians, MD, MPH, Ryan E

James T. McPhee, MD, Louis L. Nguyen, MD, MBA, MPH, Karen J. Ho, MD, C

Javier G. Jimenez, MD, Thomas S. Huber, MD, PhD, C

The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia Maria Söderström, MD,

Carotid endarterectomy with a polyurethane patch versus primary closure: A prospective randomized study Dallit Mannheim, MD, Boaz Weller, MD, Eran Vahadim,

The influence of metabolic syndrome on hemodialysis access patency

Reconstructive surgery for complex aortoiliac occlusive disease in young adults Enzo Ballotta, MD, Renata Lorenzetti, MD, Giacomo Piatto, MD, Francesca.

Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

Surgical management of severe acute lower extremity ischemia

Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia Karan.

A metropolitan experience with infrainguinal revascularization

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein

Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia Catherine K. Chang, MD, Salvatore.

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Presentation transcript:

Lower extremity arterial reconstruction for critical limb ischemia in diabetes Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai, MD, Giuseppe Da Giau, MD Journal of Vascular Surgery Volume 59, Issue 3, Pages 708-719 (March 2014) DOI: 10.1016/j.jvs.2013.08.103 Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 1 Kaplan-Meier life-table analysis of primary patency rates for diabetes mellitus (DM) and no diabetes mellitus (nDM) patients (odds ratio [OR], 1.20; 95% confidence interval [CI], 0.97-1.52; log-rank test, P = .09), for DM and nDM patients using vein graft (OR, 1.19; 95% CI, 0.94-1.54; log-rank test, P = .13) or polytetrafluoroethylene (PTFE) graft (OR, 1.03; 95% CI, 0.60-1.77; log-rank test, P = .89). Raw number of the limbs at risk and the standard error (SE) analyzed for each interval are shown for each subgroup. The SE exceeds 10% after 4 years only in the nDM group using PTFE graft. Journal of Vascular Surgery 2014 59, 708-719DOI: (10.1016/j.jvs.2013.08.103) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 2 Kaplan-Meier life-table analysis of assisted primary patency rates for diabetes mellitus (DM) and no diabetes mellitus (nDM) patients (odds ratio [OR], 1.06, 95% confidence interval [CI], 0.83-1.36; log-rank test, P = .60), for DM and nDM patients using vein graft (OR, 1.07; 95% CI, 0.82-1.40; log-rank test, P = .57) or polytetrafluoroethylene (PTFE) graft (OR, 0.83, 95% CI, 0.44-1.54; log-rank test, P = .56). Raw number of the limbs at risk and the standard error (SE) analyzed for each interval are shown for each subgroup. The SE exceeds 10% after 4 years in the DM and nDM groups using PTFE graft. Journal of Vascular Surgery 2014 59, 708-719DOI: (10.1016/j.jvs.2013.08.103) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 3 Kaplan-Meier life-table analysis of secondary patency rates for diabetes mellitus (DM) and no diabetes mellitus (nDM) patients (odds ratio [OR], 1.18; 95% confidence interval [CI], 0.91-1.56; log-rank test, P = .20), for DM and nDM patients using vein graft (OR, 1.19; 95% CI, 0.89-1.60; log-rank test, P = .23) or polytetrafluoroethylene (PTFE) graft (OR, 0.96; 95% CI, 0.47-1.95; log-rank test, P = .91). Raw number of the limbs at risk and the standard error (SE) analyzed for each interval are shown for each subgroup. The SE exceeds 10% after 4 years only in the DM group using PTFE graft. Journal of Vascular Surgery 2014 59, 708-719DOI: (10.1016/j.jvs.2013.08.103) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 4 Kaplan-Meier life-table analysis of limb salvage rates for diabetes mellitus (DM) and no diabetes mellitus (nDM) patients (odds ratio [OR], 1.32; 95% confidence interval [CI], 0.91-1.96; log-rank test, P = .12), for DM and nDM patients using vein graft (OR, 1.38; 95% CI, 0.93-2.10; log-rank test, P = .10) or polytetrafluoroethylene (PTFE) graft (OR, 0.81; 95% CI, 0.26-2.48; log-rank test, P = .71). Raw number of the limbs at risk and the standard error (SE) analyzed for each interval are shown for each subgroup. The SE exceeds 10% after 4 years only in the nDM group using PTFE graft. Journal of Vascular Surgery 2014 59, 708-719DOI: (10.1016/j.jvs.2013.08.103) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 5 Kaplan-Meier life-table analysis of survival rates for diabetes mellitus (DM) and no diabetes mellitus (nDM) patients (odds ratio [OR], 1.08; 95% confidence interval [CI], 0.88-1.33; log-rank test, P = .41). Raw number of the patients at risk and the standard error (SE) analyzed for each interval are shown for each subgroup. Journal of Vascular Surgery 2014 59, 708-719DOI: (10.1016/j.jvs.2013.08.103) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 6 Kaplan-Meier life-table analysis of amputation-free survival rates for diabetes mellitus (DM) and no diabetes mellitus (nDM) patients (odds ratio [OR], 1.12, 95% confidence interval [CI], 0.94-1.35; log-rank test, P = .19). Raw number of the patients at risk and the standard error (SE) analyzed for each interval are shown for each subgroup. Journal of Vascular Surgery 2014 59, 708-719DOI: (10.1016/j.jvs.2013.08.103) Copyright © 2014 Society for Vascular Surgery Terms and Conditions